111 related articles for article (PubMed ID: 26770927)
1. Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.
Kim GH; Chung JW; Lee JH; Ok KS; Jang ES; Kim J; Shin CM; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH; Kim JW
Clin Mol Hepatol; 2015 Dec; 21(4):379-86. PubMed ID: 26770927
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record.
Corey KE; Kartoun U; Zheng H; Shaw SY
Dig Dis Sci; 2016 Mar; 61(3):913-9. PubMed ID: 26537487
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Testosterone Replacement Therapy on Nonalcoholic Fatty Liver Disease in Older Hypogonadal Men.
Lee HS; Han SH; Swerdloff R; Pak Y; Budoff M; Wang C
J Clin Endocrinol Metab; 2024 Jan; 109(2):e757-e764. PubMed ID: 37656011
[TBL] [Abstract][Full Text] [Related]
4. Can Baseline Characteristics be Used to Predict Liver Disease Outcomes in Pediatric Nonalcoholic Fatty Liver Disease?
Orkin S; Yodoshi T; Sun Q; Fei L; Meryum S; Arce-Clachar AC; Bramlage K; Beck AF; Mouzaki M
Obesity (Silver Spring); 2021 Jan; 29(1):171-176. PubMed ID: 33185977
[TBL] [Abstract][Full Text] [Related]
5. Association of statins with nonalcoholic fatty liver disease in patients with diabetes.
Shah R; Kong A; De Melo S; Boktor M; Henriquez R; Mandalia A; Samant H; Alvarez CA; Mansi IA
J Investig Med; 2024 May; ():10815589241248076. PubMed ID: 38594224
[TBL] [Abstract][Full Text] [Related]
6. A Customized Online Nutrition Guidance System Is Effective for Treating Patients with Nonalcoholic Fatty Liver Disease by Supporting Continuity of Diet Therapy at Home: A Pilot Study.
Aoyama T; Takada H; Uchiyama A; Kon K; Yamashina S; Ikejima K; Ban H; Watanabe S
Intern Med; 2017; 56(13):1651-1656. PubMed ID: 28674352
[TBL] [Abstract][Full Text] [Related]
7. Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease.
Kandel A; Pant P; Todi S; Kc S; Pandey S
SAGE Open Med; 2024; 12():20503121241227090. PubMed ID: 38283643
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?
Berasain C; Avila MA
Cell Mol Gastroenterol Hepatol; 2021; 11(1):291-293. PubMed ID: 32971038
[No Abstract] [Full Text] [Related]
9. Vitamin E - a cause for concern?
Donnelly PE
Clin Med (Lond); 2018 Oct; 18(5):439-440. PubMed ID: 30287449
[No Abstract] [Full Text] [Related]
10. Vitamin E Acetate Is Associated with Select Proinflammatory Cytokines: An Analysis of a 2020-2022 Cohort of EVALI Patients.
Callahan SJ; Beck E; Blagev D; Harris D; Lanspa M; Brown S; Reilly CA; Paine R; Warren KJ
Am J Respir Crit Care Med; 2024 Jun; 209(11):1404-1407. PubMed ID: 38530102
[No Abstract] [Full Text] [Related]
11. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
[TBL] [Abstract][Full Text] [Related]
12. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease.
Heebøll S; Kreuzfeldt M; Hamilton-Dutoit S; Kjær Poulsen M; Stødkilde-Jørgensen H; Møller HJ; Jessen N; Thorsen K; Kristina Hellberg Y; Bønløkke Pedersen S; Grønbæk H
Scand J Gastroenterol; 2016; 51(4):456-64. PubMed ID: 26784973
[TBL] [Abstract][Full Text] [Related]
13. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
Del Ben M; Polimeni L; Baratta F; Pastori D; Angelico F
Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185
[TBL] [Abstract][Full Text] [Related]
14. Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease.
Oliveira CP; de Lima Sanches P; de Abreu-Silva EO; Marcadenti A
J Diabetes Res; 2016; 2016():4597246. PubMed ID: 26770987
[TBL] [Abstract][Full Text] [Related]
15. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
[TBL] [Abstract][Full Text] [Related]
16. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.
Chen G; Ni Y; Nagata N; Xu L; Ota T
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Parasitic Diarrhea in Patients with Common Variable Immune Deficiency.
Uysal S; Tunalı V; Akdur Öztürk E; Ardeniz Ö; Işıkgöz Taşbakan M; Pullukçu H; Özensoy Töz S; Turgay N; Arda B
Turkiye Parazitol Derg; 2016 Jun; 40(2):67-71. PubMed ID: 27594285
[TBL] [Abstract][Full Text] [Related]
18. [Infection status and virulent genes of Aeromonas in diarrhea patients in Pudong New Area, Shanghai].
Wang W; Wang D; Zhu L; Fu Y; Hao L; Xu X; Su J; Fu H; Ye C; Sun Q; Zheng Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):402-5. PubMed ID: 27005546
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation.
Brunt EM
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771611
[TBL] [Abstract][Full Text] [Related]
20. Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.
Wei J; Lei GH; Fu L; Zeng C; Yang T; Peng SF
PLoS One; 2016; 11(1):e0147985. PubMed ID: 26824361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
